Archford Capital Strategies, LLC Astrazeneca PLC Transaction History

Archford Capital Strategies, LLC

  • $643 Million
  • Q4 2024

A detailed history of Archford Capital Strategies, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 5,401 shares of AZN stock, worth $401,996. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,401
Previous 5,407 0.11%
Holding current value
$401,996
Previous $421,000 16.15%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$63.2 - $79.58 $379 - $477
-6 Reduced 0.11%
5,401 $353,000
Q3 2024

Oct 15, 2024
SELL
$76.67 - $87.62 $95,990 - $109,700
-1,252 Reduced 18.8%
5,407 $421,000
Q1 2024

Apr 24, 2024
SELL
$61.03 - $69.57 $18,492 - $21,079
-303 Reduced 4.35%
6,659 $451,000
Q4 2023

Jan 12, 2024
SELL
$61.89 - $69.28 $76,248 - $85,352
-1,232 Reduced 15.04%
6,962 $468,000
Q3 2023

Oct 27, 2023
SELL
$64.85 - $71.7 $103,241 - $114,146
-1,592 Reduced 16.27%
8,194 $554,000
Q2 2023

Aug 02, 2023
BUY
$69.91 - $75.81 $155,619 - $168,753
2,226 Added 29.44%
9,786 $700,000
Q1 2023

Apr 18, 2023
SELL
$63.15 - $71.6 $32,964 - $37,375
-522 Reduced 6.46%
7,560 $524,000
Q3 2022

Oct 17, 2022
SELL
$53.02 - $135.75 $4,135 - $10,588
-78 Reduced 0.96%
8,082 $443,000
Q2 2022

Jul 12, 2022
BUY
$59.26 - $71.14 $483,561 - $580,502
8,160 New
8,160 $539,000
Q1 2022

Apr 18, 2022
SELL
$55.72 - $67.12 $467,713 - $563,405
-8,394 Closed
0 $0
Q4 2021

Jan 20, 2022
SELL
$54.02 - $63.83 $16,422 - $19,404
-304 Reduced 3.5%
8,394 $489,000
Q3 2021

Oct 14, 2021
BUY
$55.56 - $60.79 $222 - $243
4 Added 0.05%
8,698 $522,000
Q2 2021

Jul 23, 2021
SELL
$48.42 - $60.18 $61,299 - $76,187
-1,266 Reduced 12.71%
8,694 $521,000
Q1 2021

Apr 26, 2021
SELL
$47.16 - $54.44 $1.81 Million - $2.09 Million
-38,304 Reduced 79.36%
9,960 $506,000
Q4 2020

Jan 19, 2021
BUY
$48.52 - $58.02 $1,843 - $2,204
38 Added 0.08%
48,264 $2.46 Million
Q3 2020

Oct 19, 2020
SELL
$53.07 - $61.1 $17,035 - $19,613
-321 Reduced 0.66%
48,226 $2.64 Million
Q2 2020

Jul 24, 2020
SELL
$43.1 - $55.31 $2,887 - $3,705
-67 Reduced 0.14%
48,547 $2.57 Million
Q1 2020

Apr 29, 2020
BUY
$37.79 - $51.33 $23,203 - $31,516
614 Added 1.28%
48,614 $2.17 Million
Q4 2019

Jan 15, 2020
SELL
$42.46 - $50.46 $219,178 - $260,474
-5,162 Reduced 9.71%
48,000 $2.39 Million
Q3 2019

Oct 23, 2019
SELL
$40.12 - $45.47 $33,740 - $38,240
-841 Reduced 1.56%
53,162 $2.37 Million
Q2 2019

Jul 18, 2019
SELL
$37.28 - $41.68 $166,194 - $185,809
-4,458 Reduced 7.63%
54,003 $2.23 Million
Q1 2019

May 13, 2019
SELL
$35.49 - $43.02 $52,631 - $63,798
-1,483 Reduced 2.47%
58,461 $2.36 Million
Q4 2018

Feb 13, 2019
BUY
$36.86 - $41.49 $2,617 - $2,945
71 Added 0.12%
59,944 $2.28 Million
Q3 2018

Nov 14, 2018
SELL
$34.76 - $39.72 $257,849 - $294,642
-7,418 Reduced 11.02%
59,873 $2.37 Million
Q2 2018

Aug 14, 2018
SELL
$34.55 - $37.05 $224,402 - $240,639
-6,495 Reduced 8.8%
67,291 $2.36 Million
Q1 2018

May 14, 2018
BUY
$32.97 - $36.63 $1.55 Million - $1.72 Million
46,976 Added 175.22%
73,786 $2.56 Million
Q4 2017

Feb 16, 2018
SELL
$32.09 - $34.78 $1.54 Million - $1.67 Million
-47,982 Reduced 64.15%
26,810 $930,000
Q3 2017

Nov 17, 2017
BUY
$28.96 - $34.0 $8,659 - $10,166
299 Added 0.4%
74,792 $2.53 Million
Q2 2017

Aug 18, 2017
BUY
N/A
50,006 Added 204.21%
74,493 $954,000
Q2 2017

Aug 18, 2017
BUY
N/A
24,487
24,487 $2.31 Million

Others Institutions Holding AZN

# of Institutions
1,343
Shares Held
477M
Call Options Held
5.29M
Put Options Held
3.79M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $231B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email